Geoffrey M Dusheiko

Geoffrey M Dusheiko

UNVERIFIED PROFILE

Are you Geoffrey M Dusheiko?   Register this Author

Register author
Geoffrey M Dusheiko

Geoffrey M Dusheiko

Publications by authors named "Geoffrey M Dusheiko"

Are you Geoffrey M Dusheiko?   Register this Author

25Publications

562Reads

28Profile Views

Hepatitis B virus infection.

Nat Rev Dis Primers 2018 06 7;4:18035. Epub 2018 Jun 7.

Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrdp.2018.35DOI Listing
June 2018

Conceptual framework for outcomes research studies of hepatitis C: an analytical review.

Infect Drug Resist 2016 27;9:101-17. Epub 2016 May 27.

The University College London Medical Institute for Liver and Digestive Health, London, UK; Kings College Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/IDR.S99329DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890693PMC
June 2016

Chronic Hepatitis B Virus Infection: Disease Revisit and Management Recommendations.

J Clin Gastroenterol 2016 Apr;50(4):286-94

*Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam Road, Hong Kong†Department of Internal Medicine, Yonsei University College of Medicine, Brain Korea 21 Project for Medical Science, Seoul, South Korea‡Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan§Royal Free and University College, School of Medicine, London, UK∥Hepatology Unit and Key Laboratory for Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, China¶Southwestern Medical Center, University of Texas, Dallas, TX#The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Ichikawa, Japan**INSERM Unité 1052, Cancer Research Center of Lyon, Lyon University, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCG.0000000000000478DOI Listing
April 2016

Sustained virologic response rates with telaprevir-based therapy in treatment-naive patients evaluated by race or ethnicity.

J Clin Gastroenterol 2015 Apr;49(4):336-44

*Department of Medicine and Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL †Duke Clinical Research Institute, Durham ‡University of North Carolina at Chapel Hill, Chapel Hill, NC §University of Pennsylvania School of Medicine, Philadelphia, PA ∥Department of Medicine, University of Florida, Gainesville, FL ¶California Pacific Medical Center, San Francisco, CA #Vertex Pharmaceuticals Incorporated, Cambridge, MA **Janssen Research & Development, Titusville, NJ ††Royal Free and University College, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCG.0000000000000150DOI Listing
April 2015

Hepatitis C.

Lancet 2015 Mar 14;385(9973):1124-35. Epub 2015 Feb 14.

Institute of Liver and Digestive Health, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(14)62401-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878852PMC
March 2015

Sofosbuvir and ribavirin in HCV genotypes 2 and 3.

N Engl J Med 2014 May 4;370(21):1993-2001. Epub 2014 May 4.

From the Johann Wolfgang Goethe University Medical Center, Frankfurt am Main, Germany (S.Z.); Royal Free Hospital and University College London School of Medicine, London (G.M.D.); Tartu University Hospital, Tartu, Estonia (R.S.); Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy (A.M.); Medical University of Bialystok, Bialystok, Poland (R.F.); Gilead Sciences, Foster City, CA (R.H.H., A.I., E.S., D.M.B., W.T.S., G.M.S., J.G.M.); Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm (O.W.); Academic Medical Center, Amsterdam (H.W.R.); Medical University of Vienna, Vienna (P.F.); Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Université Paris-Est, INSERM Unité 955, Créteil, France (C.H.); and Hospital Universitario Val d'Hebron, Barcelona (R.E.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1316145DOI Listing
May 2014

Treatment decisions and contemporary versus pending treatments for hepatitis C.

Nat Rev Gastroenterol Hepatol 2013 Dec 10;10(12):713-28. Epub 2013 Sep 10.

UCL Institute for Liver and Digestive Health, Royal Free London NHS Foundation Trust, Rowland Hill Street, London NW3 2PF, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrgastro.2013.163DOI Listing
December 2013

TMC435 for the treatment of chronic hepatitis C.

Expert Opin Investig Drugs 2012 Aug 23;21(8):1193-209. Epub 2012 May 23.

Royal Free Hospital, UCL Medical School, Centre for Hepatology, Rowland Hill Street, London, NW3 2PF, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2012.690392DOI Listing
August 2012

Boceprevir: an oral protease inhibitor for the treatment of chronic HCV infection.

Expert Rev Anti Infect Ther 2012 Mar;10(3):269-79

Centre for Hepatology, UCL Medical School, Royal Free Hospital, Rowland Hill Street, London, NW3 2PF, UK.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/eri.12.8
Publisher Site
http://dx.doi.org/10.1586/eri.12.8DOI Listing
March 2012

Applying a system approach to forecast the total hepatitis C virus-infected population size: model validation using US data.

Liver Int 2011 Jul;31 Suppl 2:4-17

Department of Experimental Medicine, School of Medicine, General Hospital of México, Universidad Nacional Autonoma de México, México City, México.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1478-3231.2011.02535.xDOI Listing
July 2011

Parkinsonism in patients with chronic hepatitis C treated with interferon-alpha2b: a report of two cases.

Eur J Gastroenterol Hepatol 2010 May;22(5):628-31

Centre for Hepatology, Department of Medicine, University College London Medical School, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MEG.0b013e32833383e3DOI Listing
May 2010

Cost-effectiveness of oral treatments for chronic hepatitis B.

J Hepatol 2009 Oct 6;51(4):623-5. Epub 2009 Aug 6.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2009.07.015DOI Listing
October 2009

Hepatitis C and treatment with pegylated interferon and ribavirin.

Int J Biochem Cell Biol 2004 Oct;36(10):1874-7

Royal Free and University College School of Medicine, Centre for Hepatology, Upper 3rd Floor, Royal Free Hospital, Rowland Hill Street, Hampstead, London NW3 2PF, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biocel.2004.03.014DOI Listing
October 2004

Evolution of hepatitis B virus during primary infection in humans: transient generation of cytotoxic T-cell mutants.

Gastroenterology 2004 Oct;127(4):1131-8

Department of Hepatology, Royal Free and University College Medical School, London, England, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2004.07.004DOI Listing
October 2004

Tracking the source of the hepatitis B virus-specific CD8 T cells during lamivudine treatment.

J Infect Dis 2003 Feb 29;187(4):679-82. Epub 2003 Jan 29.

Institute of Hepatology, Royal Free Campus, Royal Free and University College Medical School, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/368369DOI Listing
February 2003